Novo Nordisk expects 5-9 percent sales growth in 2021
Pharmaceutical company Novo Nordisk exceeds Q4 revenue guidance and aims for a 5-9 percent increase in local currency in 2021. This would be the same level as the sales for all of 2020.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
At the end of 2021 Novo Nordisk hopes to have scraped together a 5-9 percent revenue growth with a 4-8 percent higher operational result, both measured in local currency.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Mads Krogsgaard Thomsen resigns from Novo Nordisk
For subscribers
